AI Science Tracker

Universität zu Lübeck

1 discovery from 2025

Discoveries

PRAIM: AI finds more breast cancers in German screening

In a prospective study of over 460,000 women at twelve German sites, AI-assisted reading detected 6.7 cancers per thousand exams versus 5.7 without AI. Recall rates for further assessment were 37.4 versus 38.3 per thousand. This observational study does not show a survival benefit, and estimates of workload reduction with automated reading come from simulations.

Technology: AI support for mammogram reading (Vara)

Publication: Publication status unspecified in annotation · Test context: prospective or independent check. Catalog categories, not an evidence grade.

Result, AI contribution and limits

Evidence context (descriptions follow the cited sources; test type is a catalog classification):

  • Publication status: Not reported
  • Test type: prospective or independent check
  • Tested: A prospective study of over 460,000 women at twelve German sites (2021-2023) compared AI-assisted reading with standard double reading by radiologists: 6.7 vs 5.7 cancers per 1,000 exams.
  • Still unknown: No survival benefit is shown; workload and skipped-review figures come from simulations, and the effect on prognosis is still to be studied.
  • AI role: AI read about half of the mammograms, marking cases as normal or suspicious, with the rest read by double reading.

Evidence sources: https://www.uni-luebeck.de/aktuelles/pressemitteilung/artikel/ki-verbessert-brustkrebserkennung.html

The legacy label “Not reported” does not distinguish information absent from reviewed material from information not assessed. It is not a scientific finding of absence.

Source checked · editorial details

The source page was checked against this entry. Independent confirmation is not assessed by this label.

Source type: press release. Paper: linked separately.

Review scope and date are not recorded; source checked does not establish full-text review.

Citations: in the top 1% of works of the same type, year and subfield (OpenAlex work metrics, 280 citations; as of 15 Nov 2026). Attention, not a measure of correctness; not part of the score.

Editorial assessment: Impact 4/5 · Validation 4/5 · Novelty 3/5. Impact and novelty are editorial judgments; validation follows the annotated test type where one exists. Not an evidence grade. Scoring criteria.

Follow-up and relationships

No follow-up recorded; this is not a claim that no follow-up exists.

Follow-up review scope and date are not recorded.

No source-supported relationships recorded.

Open the interactive profile for the timeline, or browse all organizations and model families.